Cargando…

Hydrophilic Excipient-Independent Drug Release from SLA-Printed Pellets

Three-dimensional (3D) printing technology, specifically stereolithography (SLA) technology, has recently created exciting possibilities for the design and fabrication of sophisticated dosages for oral administration, paving a practical way to precisely manufacture customized pharmaceutical dosages...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Lei, Yang, Qingliang, Qiang, Wei, Li, Huijie, Zhong, Weizhen, Pan, Siying, Yang, Gensheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541594/
https://www.ncbi.nlm.nih.gov/pubmed/34684010
http://dx.doi.org/10.3390/pharmaceutics13101717
_version_ 1784589269058191360
author Xu, Lei
Yang, Qingliang
Qiang, Wei
Li, Huijie
Zhong, Weizhen
Pan, Siying
Yang, Gensheng
author_facet Xu, Lei
Yang, Qingliang
Qiang, Wei
Li, Huijie
Zhong, Weizhen
Pan, Siying
Yang, Gensheng
author_sort Xu, Lei
collection PubMed
description Three-dimensional (3D) printing technology, specifically stereolithography (SLA) technology, has recently created exciting possibilities for the design and fabrication of sophisticated dosages for oral administration, paving a practical way to precisely manufacture customized pharmaceutical dosages with both personalized properties and sustained drug release behavior. However, the sustained drug release achieved in prior studies largely relies on the presence of hydrophilic excipients in the printing formulation, which unfortunately impedes the printability and formability of the corresponding printing formulations. The current study developed and prepared mini-sized oral pellets using the SLA technique and successfully accomplished a hydrophilic excipient-independent drug release behavior. With ibuprofen as the model drug, the customized photopolymerizable printing formulation included polyethylene glycol diacrylate (PEGDA) as a monomer and diphenyl (2,4,6-trimethylbenzoyl) phosphine oxide (TPO) as a photoinitiator. The produced mini-sized pellets were thoroughly investigated for various factors, including their printability, physical properties, microscopic features, drug content, and drug-release profiles. The drug release profiles from the printed pellets that were larger size (3 mm and 6 mm) followed the Ritger–Peppas model, demonstrating that the release was influenced by both the diffusion of the dissolved drug and by the erosion of the hydrophilic excipients (PEG400). The profiles from the smaller printed pellets (1 mm and 2 mm) followed first release kinetics, not only illustrating that the release was impacted only by drug diffusion, but also indicating that there is a size boundary between the dependent and independent hydrophilic excipients. These results could create practical benefits to the pharmaceutical industry in terms of the design and development personalized dosages using the SLA printing technique with controllable drug release by manipulating size alone.
format Online
Article
Text
id pubmed-8541594
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85415942021-10-24 Hydrophilic Excipient-Independent Drug Release from SLA-Printed Pellets Xu, Lei Yang, Qingliang Qiang, Wei Li, Huijie Zhong, Weizhen Pan, Siying Yang, Gensheng Pharmaceutics Article Three-dimensional (3D) printing technology, specifically stereolithography (SLA) technology, has recently created exciting possibilities for the design and fabrication of sophisticated dosages for oral administration, paving a practical way to precisely manufacture customized pharmaceutical dosages with both personalized properties and sustained drug release behavior. However, the sustained drug release achieved in prior studies largely relies on the presence of hydrophilic excipients in the printing formulation, which unfortunately impedes the printability and formability of the corresponding printing formulations. The current study developed and prepared mini-sized oral pellets using the SLA technique and successfully accomplished a hydrophilic excipient-independent drug release behavior. With ibuprofen as the model drug, the customized photopolymerizable printing formulation included polyethylene glycol diacrylate (PEGDA) as a monomer and diphenyl (2,4,6-trimethylbenzoyl) phosphine oxide (TPO) as a photoinitiator. The produced mini-sized pellets were thoroughly investigated for various factors, including their printability, physical properties, microscopic features, drug content, and drug-release profiles. The drug release profiles from the printed pellets that were larger size (3 mm and 6 mm) followed the Ritger–Peppas model, demonstrating that the release was influenced by both the diffusion of the dissolved drug and by the erosion of the hydrophilic excipients (PEG400). The profiles from the smaller printed pellets (1 mm and 2 mm) followed first release kinetics, not only illustrating that the release was impacted only by drug diffusion, but also indicating that there is a size boundary between the dependent and independent hydrophilic excipients. These results could create practical benefits to the pharmaceutical industry in terms of the design and development personalized dosages using the SLA printing technique with controllable drug release by manipulating size alone. MDPI 2021-10-17 /pmc/articles/PMC8541594/ /pubmed/34684010 http://dx.doi.org/10.3390/pharmaceutics13101717 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Xu, Lei
Yang, Qingliang
Qiang, Wei
Li, Huijie
Zhong, Weizhen
Pan, Siying
Yang, Gensheng
Hydrophilic Excipient-Independent Drug Release from SLA-Printed Pellets
title Hydrophilic Excipient-Independent Drug Release from SLA-Printed Pellets
title_full Hydrophilic Excipient-Independent Drug Release from SLA-Printed Pellets
title_fullStr Hydrophilic Excipient-Independent Drug Release from SLA-Printed Pellets
title_full_unstemmed Hydrophilic Excipient-Independent Drug Release from SLA-Printed Pellets
title_short Hydrophilic Excipient-Independent Drug Release from SLA-Printed Pellets
title_sort hydrophilic excipient-independent drug release from sla-printed pellets
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541594/
https://www.ncbi.nlm.nih.gov/pubmed/34684010
http://dx.doi.org/10.3390/pharmaceutics13101717
work_keys_str_mv AT xulei hydrophilicexcipientindependentdrugreleasefromslaprintedpellets
AT yangqingliang hydrophilicexcipientindependentdrugreleasefromslaprintedpellets
AT qiangwei hydrophilicexcipientindependentdrugreleasefromslaprintedpellets
AT lihuijie hydrophilicexcipientindependentdrugreleasefromslaprintedpellets
AT zhongweizhen hydrophilicexcipientindependentdrugreleasefromslaprintedpellets
AT pansiying hydrophilicexcipientindependentdrugreleasefromslaprintedpellets
AT yanggensheng hydrophilicexcipientindependentdrugreleasefromslaprintedpellets